Rashtriya Newsflash

Posts From admin

Fitost Reports on CoreAge Rx’s Growing Recognition as the Best GLP-1 Brand of 2026, Covering Independent Reviews Citing Consistent Top Rankings Across the Industry

Independent platforms increasingly highlight CoreAge Rx for physician-guided telehealth care, transparent pricing, and consistent rankings across GLP-1 treatment evaluations. Fitost has published a comprehensive report examining the rising industry recognition

Read Full Article

AI Detector: Detect AI Content App Launches on iOS with Multi-Format AI Detection Features

AI Detector: Detect AI Content introduces five integrated tools for detecting AI-generated text, images, video, and voice, along with a humanizer feature. AI Detector: Detect AI Content has been launched

Read Full Article

Pulmonary Fibrosis Clinical Trial Analysis 2026: 110+ Companies Advancing 140+ Therapies with Breakthrough Clinical Progress, analyses DelveInsight

Pulmonary Fibrosis Pipeline Pulmonary Fibrosis Companies include Boehringer Ingelheim, PureTech, Guangzhou JOYO Pharma, Tvardi Therapeutics, Pliant Therapeutics, GlaxoSmithKline, Amgen, Bristol-Myers Squibb, Endeavor Biomedicines, Syndax Pharmaceuticals, Regend Therapeutics, among others. According

Read Full Article

Obsessive Compulsive Disorder Market to Surpass USD 1 Billion by 2034 | 10+ Key Companies Driving Innovation, analyses DelveInsight

Obsessive Compulsive Disorder Market Obsessive Compulsive Disorder (OCD) companies include Biohaven Pharmaceuticals, AbbVie, AstraZeneca, MedtronicNeuro, Hoffmann-La Roche, Ortho-McNeil Pharmaceutical, Forest Laboratories, Eli Lilly and Company, Janssen-Ortho Inc., Pfizer, among others.

Read Full Article

Alcohol Use Disorder Pipeline Report 2026 Highlights 30+ Companies and 30+ Therapies Shaping Future Treatment Trends, analyses DelveInsight

Alcohol Use Disorder Pipeline Alcohol Use Disorder companies include Pear Therapeutics, Cybin, Lohocla Research, BioXcel Therapeutics, Pop Test Oncology, Dicerna

Read Full Article

Hepatocellular Carcinoma Drug Development Landscape Gains Momentum with Over 90 Companies Advancing Innovative Therapies | DelveInsight

Hepatocellular Carcinoma Pipeline Leading Hepatocellular Carcinoma companies involved in this space include Can-Fite BioPharma, Surface Oncology, Novartis Oncology, GlaxoSmithKline, CStone

Read Full Article

Esophageal Cancer Clinical Trial Landscape Gains Momentum as 80+ Biopharma Players Advance Next-Generation Therapies | DelveInsight

Esophageal Cancer Clinical Trials Esophageal Cancer Companies include OncoTherapy Science/Shionogi & Co., Oncolys BioPharma, Lyvgen Biopharma, Adlai Nortye Biopharma, NovaRock

Read Full Article

Hemophilia Clinical Development Landscape Strengthens as 80+ Companies Drive Innovation | DelveInsight

Hemophilia Pipeline Prominent Hemophilia companies include Centessa Pharmaceuticals, Alnylam Pharmaceuticals, ASC Therapeutics, Spark Therapeutics, Freeline Therapeutics, BioMarin Pharmaceutical, Staidson Beijing

Read Full Article

Head and Neck Cancer Clinical Pipeline Accelerates: Over 80 Companies Advancing 100+ Innovative Therapies | DelveInsight

Head and Neck Cancer Pipeline Major Head and Neck Cancer companies driving innovation include Merus, Bicara Therapeutics, Kura Oncology, Theriva

Read Full Article

Muscle Invasive Bladder Cancer Market Set for Strong Growth Through 2034, Driven by Expanding Pipeline and Innovation | DelveInsight

Muscle Invasive Bladder Cancer Market The Muscle Invasive Bladder Cancer (MIBC) treatment landscape is undergoing rapid transformation, fueled by an

Read Full Article